Cancer Reversals with Holistic Immunotherapy

Strong evidence exists for an inverse correlation between the incidence of infectious diseases and cancer risk and an inverse correlation between febrile infections and remissions of malignancies.

A review of the literature to a key word search was undertaken, using the following key words: fever, infectious diseases, neoplasm, cancer incidence and spontaneous remission.

Conclusion: The data reviewed in the Institute’s blog on hyperthermia is support earlier observations on the topic, i.e. that the occurrence of fever in childhood or adulthood may protect against the later onset of malignant disease and that spontaneous remissions are often preceded by feverish infections.

Pyrogenic substances and the more recent use of whole-body hyperthermia to mimic the physiologic response to fever have successfully been administered in palliative and curative treatment protocols for metastatic cancer.

Part of the Institute’s Protocole.

 

References

Friedman H, Butler RC, Nowotny A: Enhanced antibody response in retrovirus-infected mice treated with endotoxin or nontoxic polysaccharide derivative. Proc Soc Exp Biol Med 1987;186:275–279.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Friedman H, Blanchard DK, Newton C, Klein T, Stewart W 2nd, Keler T, Nowotny A: Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures. J Biol Response Mod 1987;6:664–677.External Resources

Pubmed/Medline (NLM)

Bokemeyer C, Kuczyk MA, Kohne CH, Haupt A, Schmoll HJ: Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis (in German). Med Klin 1996;91:703–710.External Resources

Pubmed/Medline (NLM)

Malpas JS: Long-term effects of treatment of childhood malignancy. Clin Radiol 1996;51:466–474.External Resources

Pubmed/Medline (NLM)

Shapiro CL, Recht A: Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 1994;(16):101–112. 

Krainer M, Wolf H, Michl I, Wiltschke C, Budinsky A, Kaider A, Kratzik C, Eibl MM, Zielinski CC: Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease. Cancer 1995;75:539–544.External Resources

Pubmed/Medline (NLM)

Rutqvist LE: Long-term toxicity of tamoxifen. Recent Results Cancer Res 1993;127:257–266.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Albanell J, Gallego OS, Bellmunt J, Vicente P, Morales S, Sole LA: Bladder neoplasm in a patient with panarteritis nodosa treated with cyclophosphamide (in Spanish). Rev Clin Esp 1992;190:463–465.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Forbes JF: Long-term effects of adjuvant chemotherapy in breast cancer. Acta Oncol 1992;31:243–250.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Zielinski CC, Muller C, Kubista E, Staffen A, Eibl MM: Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms. Acta Med Austriaca 1990;17:11–14.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Zielinski CC, Muller C, Tichatschek E, Aiginger P: Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy. Br J Cancer 1989;60:712–714.External Resources

Pubmed/Medline (NLM)

Zielinski CC, Stuller I, Dorner F, Potzi P, Muller C, Eibl MM: Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy. Cancer 1986;58:1648–1652.External Resources

Pubmed/Medline (NLM)

Tichatschek E, Zielinski CC, Muller C, Sevelda P, Kubista E, Czerwenka K, Spona J, Wolf H, Eibl MM: Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother 1988;27:278–282.External Resources

Pubmed/Medline (NLM)

Kempf RA, Mitchell MS: Effects of chemotherapeutic agents on the immune response. II. Cancer Invest 1985;3:23–33.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Cole WH, Humphrey L: Need for immunologic stimulators during immunosuppression produced by major cancer surgery. 1985;202:9–20. 

Cole WH: The increase in immunosuppression and its role in the development of malignant lesions. J Surg Oncol 1985;30:139–144.External Resources

Pubmed/Medline (NLM)

Bailar JC 3rd, Smith EM: Have we reduced the risk of getting cancer or of dying from cancer? An update. Med Oncol Tumor Pharmacother 1987;4:193–198.External Resources

Pubmed/Medline (NLM)

Bailar JC 3rd, Gornik HL: Cancer undefeated. N Engl J Med 1997;336:1569–1574.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Abel U: Chemotherapy of advanced epithelial cancer – a critical review. Biomed Pharmacother 1992;46:439–452.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Cambridge Scientific Abstracts (CSA)

Schipper H, Goh CR, Wang TL: Shifting the cancer paradigm: Must we kill to cure? (editorial). J Clin Oncol 1995;13:801–807.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Schipper H, Turley EA, Baum M: A new biological framework for cancer research. Lancet 1996;348:1149–1151.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Cambridge Scientific Abstracts (CSA)

Sporn MB: The war on cancer. Lancet 1996;347:1377–1381.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Cambridge Scientific Abstracts (CSA)

Coley WB: Treatment of inoperable malignant tumors with toxins of erysipelas and the Bacillus prodigiosus. Trans Am Surg Assoc 1894;12:183–212. 

Coley WB: Inoperable sarcoma: A further report of cases successfully treated with the mixed bacterial toxins of erysipelas and Bacillus prodigiosus. Med Rec 1907;72:129–137. 

Coley WB: Further observations upon the treatment of malignant tumors with the toxins of erysipelas and Bacillus prodigiosus with a report of 160 cases. Bull Johns Hopkins Hosp 1896;7:175. 

Coley WB: A report of recent cases of inoperable sarcomas successfully treated with mixed toxines of erysipelas and Bacillus prodigiosus. Surg Gynecol Obstet 1911;13:174–190. 

Coley WB: Endothelioma myeloma of tibia: Long-standing cure by toxin treatment. Ann Surg 1931;94:447–452. 

Coley WB: The therapeutic value of the mixed toxins of the streptococcus of erysipelas and Bacillus prodigiosus in the treatment of inoperable malignant tumors. With a report of 160 cases. Am J Med Sci 1896;112:251–281. 

Coley WB: The treatment of inoperable sarcoma by bacterial toxines (the mixed toxines of the streptococcus of erysipelas and the Bacillus prodigiosus). Practitioner 1909;83:589–613. 

Coley WB: The treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original cases. Am J Med Sci 1893;105:487–511. 

Coley WB, Coley BL: Primary malignant tumors of the long bones. Arch Surg 1926;13/14:63–141. 

Wiemann B, Starnes CO: Coley’s toxins, tumor necrosis factor and cancer research: A historical perspective. Pharmacol Ther 1994;64:529–564.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Gidlof C, Dohlsten M, Lando P, Kalland T, Sundstrom C, Totterman TH: A superantigen-antibody fusion protein for T cell immunotherapy of human B-lineage malignancies. Blood 1997;89:2089–2097.External Resources

Pubmed/Medline (NLM)

Hansson J, Ohlsson L, Persson R, Andersson G, Ilback NG, Litton MJ, Kalland T, Dohlsten M: Genetically engineered superantigens as tolerable antitumor agents. Proc Natl Acad Sci USA 1997;94:2489–2494.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Bluming AZ, Vogel CL, Ziegler JL, Mody N, Kamya G: Immunological effects of BCG in malignant melanoma: Two modes of administration compared. Ann Intern Med 1972;76:405–411.External Resources

Pubmed/Medline (NLM)

Hakim AA, Grand NG: Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses. J Pharm Sci 1976;65:339–343.External Resources

Pubmed/Medline (NLM)

Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, Prescott S, Chisholm GD, James K: Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guerin (BCG) immunotherapy. Clin Exp Immunol 1995;99:369–375.External Resources

Pubmed/Medline (NLM)

Jackson AM, Alexandrov AB, Prescott S, James K: Production of urinary tumour necrosis factors and soluble tumour necrosis factor receptors in bladder cancer patients after bacillus Calmette-Guerin immunotherapy. Cancer Immunol Immunother 1995;40:119–124.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Jurincic-Winkler C, Metz KA, Beuth J, Sippel J, Klippel KF: Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guerin (BCG) instillation on carcinoma in situ of the urinary bladder. Anticancer Res 1995;15:2771–2776.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Mastrangelo MJ, Kim YH, Bornstein RS, Chee DO, Sulit HL, Yarbro JW, Prehn RT: Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: A case report. J Natl Cancer Inst 1974;52:19–24.External Resources

Pubmed/Medline (NLM)

Morales A: From the 19th to the 21st centuries: BCG in the treatment of superficial bladder cancer. Eur Urol 1992;21(suppl 2):2–6. 

Laurence JZ: The diagnosis of surgical cancer (the Liston prize essay for 1854). London, Churchill, 1855, p 56. 

Schmidt KL: Krebs und Infektionskrankheiten. Med Klin 1910;43:1690–1693. 

Engel P: Über den Infektionsindex der Krebskranken. Wien Klin Wochenschr 1934;47:1118–1119. 

Engel P: Über den Einfluss des Alters auf den Infektionsindex der Krebskranken. Wien Klin Wochenschr 1935;48:112. 

Sinek F: Versuch einer statistischen Erfassung endogener Faktoren bei Carcinomerkrankungen. Z Krebsforsch 1936;44:492–527. 

Witzel L: Anamnese und Zweiterkrankungen bei Patienten mit bösartigen Neubildungen. Med Klin 1970;65:876–879.External Resources

Pubmed/Medline (NLM)

Newhouse ML, Pearson RM, Fullerton JM, Boesen EAM, Shannon HS: A case control study of carcinoma of the ovary. Br J Prev Soc Med 1977;31:148–153.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Remy W, Hammerschmidt K, Zänker KS, Ulm K, Theisinger W, Lange J, Trappe A, Maubach PA, Rastetter J: Tumorträger haben selten Infekte in der Anamnese. Med Klin 1983;78:95–98. 

Grufferman S, Wang HH, DeLong ER, Kimm SY, Delzell ES, Falletta JM: Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst 1982;68:107–113.External Resources

Pubmed/Medline (NLM)

Rønne T: Measles virus infection without rash in children is related to disease in adult life. Lancet 1985;i:1–5. 

van Steensel-Moll HA, Valkenburg HA, van Zanen GE: Childhood leukemia and infectious diseases in the first year of life: A register based case-control study. Am J Epidemiol 1985;124:590–594. 

Chilvers O, Johnson B, Leach S, Taylor C, Vigar E: The common cold, allergy, and cancer. Br J Cancer 1986;54:123–126.External Resources

Pubmed/Medline (NLM)

Abel U: Incidence of infection and cancer risk (in German). Dtsch Med Wochenschr 1986;111:1987–1981.External Resources

Pubmed/Medline (NLM)

Abel U: Cancer occurrence from the biometric viewpoint (in German). Fortschr Med 1986;104:158–162.External Resources

Pubmed/Medline (NLM)

Abel U, Becker N, Angerer R, Frentzel-Beyme R, Kaufmann M, Schlag P, Wysocki S, Wahrendorf J, Schulz G: Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991;117:339–344.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J: Medical risk factors and development of brain tumors. Cancer 1992;69:2541–2547.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Grossarth-Maticek R, Frentzel-Beyme R, Kanazir D, Jankovic M, Vetter H: Reported herpes-virus-infection, fever and cancer incidence in a prospective study. J Chronic Dis 1987;40:967–976.External Resources

Pubmed/Medline (NLM)

Kölmel KF, Compagnone D: Melanom und Atopie. Dtsch Med Wochenschr 1988;113:169–171.External Resources

Pubmed/Medline (NLM)

Kölmel KF, Gefeller O, Haferkamp B: Febrile infections and malignant melanoma: Results of a case-control study. Melanoma Res 1992;2:207–211.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Cooper GS, Kamel F, Sandler DP, Davey FR, Bloomfield CD: Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Biomarkers Prev 1996;5:867–872.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Goldstein DJ, Austin JH, Zuech N, Williams DL, Stoopler MB, Michler RE, Schulman LL: Carcinoma of the lung after heart transplantation. Transplantation 1996;62:772–775.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Swinnen LJ: Transplant immunosuppression-related malignant lymphomas. Cancer Treat Res 1993;66:95–110.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Hoover RN: Lymphoma risks in populations with altered immunity – a search for mechanism. Cancer Res 1992;52(19 suppl):5477s–5478s. 

Thomas JA, Crawford DH: B-cell lymphoma in organ transplant recipients. Semin Thorac Cardiovasc Surg 1990;2:221–232.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Shiba T, Noguchi S, Yao M, Takahashi T, Shuin T, Miura T, Kinoshita Y, Kubota Y, Hosaka M: Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener’s granuloma: A case report (in Japanese). Hinyokika Kiyo 1991;37:393–396.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Forbes A, Reading NG: Review article: The risks of malignancy from either immunosuppression or diagnostic radiation in inflammatory bowel disease. Aliment Pharmacol Ther 1995;9:465–470.External Resources

Pubmed/Medline (NLM)

Draper GJ: General overview of studies of multigeneration carcinogenesis in man, particularly in relation to exposure to chemicals. IARC Sci Publ 1989;(96):275–288. 

Penn I: Cancers after cyclosporine therapy. Transplant Proc 1988;20(1 suppl 1):276–279. 

Penn I: Posttransplant malignancies in pediatric organ transplant recipients. Transplant Proc 1994;26:2763–2765.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Penn I: Malignancy. Surg Clin North Am 1994;74:1247–1257.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Tan-Shalaby J, Tempero M: Malignancies after liver transplantation: A comparative review. Semin Liver Dis 1995;15:156–164.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Atkins E: Fever: Its history, cause and function. Yale J Biol Med 1982;55:283–289.External Resources

Pubmed/Medline (NLM)

Kluger MJ: Fever: Role of pyrogens and cryogens. Physiol Rev 1991;71:93–127.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Roberts NJ Jr: The immunological consequences of fever; in Mackowiak PA (ed): Fever: Basic Mechanisms and Management. New York, Raven, 1991, p 125. 

Roberts NJ Jr: Impact of temperature elevation on immunologic defenses. Rev Infect Dis 1991;13:462–472.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Dinarello CA: Endogenous pyrogens; in Mackowiak PA (ed): Fever: Basic Mechanisms and Management. New York, Raven, 1991, p 23. 

Dinarello CA: Thermoregulation and the pathogenesis of fever. Infect Dis Clin North Am 1996;10:433–449.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Burnet FM: The concept of immunological surveillance. Prog Exp Tumor Res 1970;13:1–27.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Burnet FM: Implications of immunological surveillance for cancer therapy. Isr J Med Sci 1971;7:9–16.External Resources

Pubmed/Medline (NLM)

O’Regan B, Hirshberg C: Spontaneous Remission: An Annotated Bibliography. Sausalito, Institute of Noetic Sciences, 1993. 

Nauts HC: Bacterial vaccine therapy of cancer. Dev Biol Stand 1978;38:487–494. 

Nauts HC: Bacterial Products in the Treatment of Cancer: Past, Present and Future (meeting paper). International Colloquium on Bacteriology and Cancer 1982;107:687–696. 

Nauts HC: Bacterial pyrogens: Beneficial effects on cancer patients. Prog Clin Biol Res 1982;107:687–696.External Resources

Pubmed/Medline (NLM)

Nauts HC: Breast cancer: Immunological factors affecting incidence, prognosis and survival, monograph No. 18. New York, Cancer Research Institute, 1984. 

Nauts HC: Immuntherapie des Krebses; International Symposium on Endotoxin: Structural Aspects and Immunobiology of Host Responses. Riva del Sole, Giovinazzo (Bari), Italy, 29 May to 1 June, 1986 

Nauts HC: Bacteria and cancer – antagonisms and benefits. Cancer Surv 1989;8:713–723.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Nauts HC: Beneficial effects of immunotherapy (bacterial toxins) on sarcoma of the soft tissues, other than lymphosarcoma, monograph No. 16. New York, Cancer Research Institute, 1975. 

Nauts HC: Bibliography of reports concerning the clinical or experimental use of Coley toxins (Streptococcus pyogenes and Serratia marcescens), 1893–1984. New York, Cancer Research Institute, 1997. 

Nauts HC: Ewing’s sarcoma of bone: End results following immunotherapy (bacterial toxins) combined with surgery and/or radiation, monograph No. 14. New York, Cancer Research Institute, 1974. 

Nauts HC: Historical perspective on the development of inbred mice. Introductory remarks; in Morse HC 3rd (ed): Origins of Inbred Mice. New York, Academic, 1978, pp 23–24. 

Nauts HC: Giant cell tumor of bone: End results following immunotherapy (Coley toxins) alone or combined with surgery and/or radiation – 66 cases and concurrent infection – 4 cases, monograph No. 4. New York, Cancer Research Institute, 1976. 

Nauts HC: Osteogenic sarcoma: End results following immunotherapy with bacterial vaccines, 165 cases or following bacterial infections inflammation or fever, 41 cases, monograph No. 15. New York, Cancer Research Institute, 1974. 

Nauts HC: The beneficial effects of bacterial infections on host resistance to cancer. End results in 449 cases. A study and abstracts of reports in the world medical literature (1775–1980) and personal communications, monograph No. 8, ed 2. New York, Cancer Research Institute, 1980. 

Nauts HC, Fowler GA: End results in lymphosarcoma treated by toxin therapy alone or combined with surgery and/or radiation or with concurrent bacterial infection, monograph No. 6. New York, Cancer Research Institute, 1969. 

Nauts HC, McLaren JR: Coley toxins – the first century. Adv Exp Med Biol 1990;267:483–500.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Nauts HC, Swift WE, Coley LB: Treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research. Cancer Res 1946;6:205–216. 

Nauts HC, Fowler GA, Bogatko FH: A review of the influence of bacterial infection and of bacterial products (Coley’s toxins) on malignant tumors in man. Acta Med Scand 1953;146(suppl 276):1–103. 

Nauts HC: Beneficial effects of acute concurrent infection, inflammation, fever or immunotherapy (bacterial toxins) on ovarian and uterine cancer, monograph No. 17. New York, Cancer Research Institute, 1977. 

Nauts HC: Enhancement of natural resistance to renal cancer: Beneficial effects of concurrent infections and immunotherapy with bacterial vaccines, monograph No. 12. New York, Cancer Research Institute, 1970. 

Nauts HC: Multiple myeloma: Beneficial effects of acute infections or immunotherapy (bacterial vaccines), monograph No. 13. New York, Cancer Research Institute, 1975. 

Vautier AH: Vue générale sur la maladie cancéreuse. Thèse Paris 1813;43:11. 

Nowotny A: Antitumor effects of endotoxins; in Berry LJ (ed): Cellular Biology of Endotoxin, vol 3, in Handbook of Endotoxin. New York, Elsevier Science, 1985, pp 389–448. 

Eschweiler R: Die Erysipel-, Erysipeltoxin- und Serumtherapie der bösartigen Geschwülste. Leipzig, Naumann, 1897. 

Rohdenburg GL: Fluctuations in the growth energy of malignant tumors in man, with especial reference to spontaneous regression. J Cancer Res 1918;3:193–225. 

Wolfenheim W: Über den heilenden Einfluss des Erysipels auf Gewebsneubildungen, insbesondere bösartige Tumoren. Z Klin Med 1921;92:507–526. 

Everson TC: Spontaneous regression of cancer. Ann NY Acad Sci 1964;114:721–735.External Resources

Pubmed/Medline (NLM)

Everson TC: Spontaneous regression of cancer. Prog Clin Cancer 1967;3:79–95.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Everson TC, Cole WH: Spontaneous regression of cancer: Preliminary report. Ann Surg 1956;144:366–383. 

Everson TC, Cole WH: Spontaneous Regression of Cancer. A Study and Abstract of Reports in the World Medical Literature and Personal Communications concerning Spontaneous Regressions of Malignant Disease. Philadelphia, Saunders, 1966. 

Stephenson HE, Delmez JA, Renden DI, Kimpton RS, Todd PC, Charron TL, Lindberg DAB: Host immunity and spontaneous regression of cancer evaluated by computerized data reduction study. Surg Gynecol Obstet 1971;133:649–655.External Resources

Pubmed/Medline (NLM)

Cole WH: Spontaneous regression of reticulum-cell sarcoma of bone. J Bone Joint Surg Am 1959;41-A:960–965. 

Cole WH: Spontaneous regression of cancer and the importance of finding its cause. Natl Cancer Inst Monogr 1976;44:5–9.External Resources

Pubmed/Medline (NLM)

Cole WH: Efforts to explain spontaneous regression of cancer. J Surg Oncol 1981;17:201–209.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Dock G: The influence of complicating diseases upon leukemia. Am J Med Sci 1904;127:563–592. 

Pelner L, Fowler GA, Nauts HC: Effects of concurrent infections and their toxins on the course of leukemia. Acta Med Scand 1958;162(suppl 338):4–47. 

Kizaki M, Ogawa T, Watanabe Y, Toyama K: Spontaneous remission in hypoplastic acute leukemia. Keio J Med 1988;37:299–307.External Resources

Pubmed/Medline (NLM)

Huth EF: Die Rolle der bakteriellen Infektionen bei der Spontanremission maligner Tumoren und Leukosen; in Lampert H, Selawry O (eds): Körpereigene Abwehr und bösartige Geschwülste. Ulm, Haug, 1957, pp 23–37. 

Takita H: Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg 1970;59:642–644.External Resources

Pubmed/Medline (NLM)

Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF: Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med 1972;287:1013–1017.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Matzker J, Steinberg A: Tonsillectomy and leukemia in adults (author’s translation). Laryngol Rhinol Otol (Stuttg) 1976;55:721–725.External Resources

Pubmed/Medline (NLM)

Kapp JP: Microorganisms as antineoplastic agents in CNS tumors. Arch Neurol 1983;40:637–642.External Resources

Pubmed/Medline (NLM)

Nowacki MP, Szymendera JJ: The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum 1983;26:263–268.External Resources

Pubmed/Medline (NLM)

Fucini C, Bandettini L, D’Elia M, Filipponi F, Herd-Smith A: Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure? Dis Colon Rectum 1985;28:94–95.External Resources

Pubmed/Medline (NLM)

Treon SP, Broitman SA: Beneficial effects of post-transfusional hepatitis in acute myelogenous leukemia may be mediated by lipopolysaccharides, tumor necrosis factor α and interferon γ. Leukemia 1992;6:1036–1042.External Resources

Pubmed/Medline (NLM)

Maurer S, Kölmel K: Spontaneous regression of melanoma, monograph No. 19. New York, Cancer Research Institute, 1997. 

Ader R (ed): Psychoneuroimmunology. New York, Academic, 1981. 

Hiramoto RN, Rogers CF, Demissie S, Hsueh CM, Hiramoto NS, Lorden JF, Ghanta VK: Psychoneuroendocrine immunology: Site of recognition, learning and memory in the immune system and the brain. Int J Neurosci 1997;92:259–285.External Resources

Pubmed/Medline (NLM)

Dantzer R, Konsman JP, Bluthe RM, Kelley KW: Neural and humoral pathways of communication from the immune system to the brain: Parallel or convergent? (review). Auton Neurosci 2000;85:60–65.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Chemical Abstracts Service (CAS)

Hori T: Cytokines and the related neurotransmitters in brain-immune interactions (review; in Japanese). Nippon Yakurigaku Zasshi 2000;115:209–218.External Resources

Pubmed/Medline (NLM)

Luheshi G, Rothwell N: Cytokines and fever. Int Arch Allergy Immunol 1996;109:301–307.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Hanson DF: Fever and the immune response. The effects of physiological temperatures on primary murine splenic T cell responses in vitro. J Immunol 1993;151:436–448.External Resources

Pubmed/Medline (NLM)

Rodbard D, Wachslicht-Rodbard H, Rodbard S: Temperature: A critical factor determining localization and natural history of infectious, metabolic, and immunological diseases. Perspect Biol Med 1980;23:439–474.External Resources

Pubmed/Medline (NLM)

Hanson DF, Murphy PA: Temperature sensitivity of interleukin-dependent murine T cell proliferation: Q2 mapping of the responses of peanut agglutinin-negative thymocytes. J Immunol 1985;135:3011–3020.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Niitsu Y, Watanabe N, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I: Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis. Cancer Res 1988;48:654–657.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Yamauchi N, Watanabe N, Maeda M, Okamoto T, Sasaki H, Tsuji Y, Umeno H, Akiyama S, Niitsu Y: Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia. Jpn J Cancer Res 1992;83:540–545.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Roberts NJ Jr, Steigbigel RT: Hyperthermia and human leukocyte functions: Effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils. Infect Immun 1977;18:673–679.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Dinarello CA, Conti P, Mier JW: Effects of human interleukin-1 on natural killer cell activity: Is fever a host defense mechanism for tumor killing? Yale J Biol Med 1986;59:97–106.External Resources

Pubmed/Medline (NLM)

Dinarello CA, Dempsey RA, Allegretta M, LoPreste G, Dainiak N, Parkinson DR, Mier JW: Inhibitory effects of elevated temperature on human cytokine production and natural killer activity. Cancer Res 1986;46:6236–6241.External Resources

Pubmed/Medline (NLM)

Boeye A, Delaet I, Brioen P: Antibody neutralization of picornaviruses: Can fever help? Trends Microbiol 1994;2:255–257.External Resources

Pubmed/Medline (NLM)

Berczi I, Bertok L, Chow DA: Natural immunity and neuroimmune host defense. Ann NY Acad Sci 2000;917:248–257.External Resources

Pubmed/Medline (NLM)

Coelho MM, Luheshi G, Hopkins SJ, Pela IR, Rothwell NJ: Multiple mechanisms mediate antipyretic action of glucocorticoids. Am J Physiol 1995;269:R527–R535.External Resources

Pubmed/Medline (NLM)

Berczi I: Neurohormonal host defense in endotoxin shock. Ann NY Acad Sci 1998;840:787–802.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Levin EJ: Spontaneous regression (cure?) of a malignant tumor of bone. Cancer 1957;10:377–381. 

Callan JE, Wood VE, Linda L: Spontaneous resolution of an osteochondroma. J Bone Joint Surg Am 1975;57:723.External Resources

Pubmed/Medline (NLM)

Copeland RL, Meehan PL, Morrissy RT: Spontaneous regression of osteochondromas. Two case reports. J Bone Joint Surg Am 1985;67:971–973.External Resources

Pubmed/Medline (NLM)

Eisenbud L, Kahn LB, Friedman E: Benign osteoblastoma of the mandible: Fifteen year follow-up showing spontaneous regression after biopsy. J Oral Maxillofac Surg 1987;45:53–57.External Resources

Pubmed/Medline (NLM)

Collignon JC, Kalangu K, Flandroy P: Benign osteoblastoma of the spine. Apropos of 4 cases with a case of spontaneous recovery (in French). Neurochirurgie 1988;34:262–270.External Resources

Pubmed/Medline (NLM)

Bluming AZ, Ziegler JL: Regression of Burkitt’s lymphoma in association with measles infection. Lancet 1971;ii:105–106. 

Margolis J, West D: Spontaneous regression of malignant disease: Report of three cases. J Am Geriatr Soc 1967;15:251–253.External Resources

Pubmed/Medline (NLM)

Rao S, Constantini S, Gomori JM, Siegal T, Epstein F: Spontaneous involution of an intra-axial brain stem lesion: A case report. Pediatr Neurosurg 1995;23:279–282.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Rebollo J, Llorente I, Yoldi A: Spontaneous tumor regression in a patient with metastatic gastric cancer. Communication of an additional case (in Spanish). Rev Med Univ Navarra 1990;34:141–142.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Zambrana Garcia JL, Torres Serrano F, Lopez Rubio F, Jimenez-Pereperez JA, Perez-Jimenez F: Spontaneous tumor regression and gastric cancer (letter; in Spanish). An Med Interna 1996;13:47–48.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Friedrich EG Jr: Reversible vulvar atypia. A case report. Obstet Gynecol 1972;39:173–181.External Resources

Pubmed/Medline (NLM)

Larsen SU, Rose C: Spontaneous remission of breast cancer. A literature review (in Danish). Ugeskr Laeger 1999;161:4001–4004.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Kruse J: Spontaneous remission of breast cancer (in Danish; comment on Ugeskr Laeger 1999;161:4001–4004). Ugeskr Laeger 1999;161:5330–5331. 

Temesrekasi D: Complete regression of 2 non-operated hypopharyngeal carcinomas (in German). Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1969;194:323–328.External Resources

Pubmed/Medline (NLM)

Woods JE: The influence of immunologic responsiveness on head and neck cancer. Therapeutic implications. Plast Reconstr Surg 1975;56:77–80.External Resources

Pubmed/Medline (NLM)

Chien RN, Chen TJ, Liaw YF: Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 1992;87:903–905.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Grossmann M, Hoermann R, Weiss M, Jauch KW, Oertel H, Staebler A, Mann K, Engelhardt D: Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 1995;90:1500–1503.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Markovic S, Ferlan-Marolt V, Hlebanja Z: Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 1996;91:392–393.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Cambridge Scientific Abstracts (CSA)

Tarazov PG: Spontaneous necrosis of liver cancer: One more possible cause (letter; comment). Am J Gastroenterol 1996;91:1872–1873. 

Dreyfus B: Les remissions de la leucemie aigue. Sangre 1988;1:35–40. 

Bassen FA, Kohn JL: Multiple spontaneous remissions in a child with acute leukemia. The occurrence of agranulocytosis and aplastic anemia in acute leukemia and their relationship to remissions. Blood 1952;7:37–46. 

Paolino W, Sartoris S: Due casi di leucemia migliorati a seguito di complicazioni infettive. Minerva Med 1960;51:34554–34556. 

Vladimirskaia EB: A case of prolonged spontaneous remission in a patient with chronic lymphatic leukemia. Problemy Gematol Pereliv Krovi 1962;7:51–54. 

Hardisty RM: Splenic aspiration in acute leukaemia. Lancet 1968;i:472–473. 

Burgess MA, de Gruchy GC: Septicaemia in acute leukaemia. Med J Aust 1969;1:1113–1117.External Resources

Pubmed/Medline (NLM)

Wyszkowski J, Armata J, Cyklis R, Halikowski B: Remission in acute drug-resistant leukemia complicated with steroid diabetes and severe infection (in Polish). Pol Tyg Lek 1969;24:1974–1975.External Resources

Pubmed/Medline (NLM)

Wiernik PH: Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr 1976;44:35–38.External Resources

Pubmed/Medline (NLM)

Chemical Abstracts Service (CAS)

Barton JC, Conrad ME: Beneficial effect of hepatitis in patients with acute myelogenous leukemia. Ann Intern Med 1979;90:188–190.External Resources

Pubmed/Medline (NLM)

Conrad ME, Barton JC: Hepatitis and leukemia (letter). Ann Intern Med 1979;90:988.External Resources

Pubmed/Medline (NLM)

Foon KA, Yale C, Clodfelter K, Gale RP: Posttransfusion hepatitis in acute myelogenous leukemia: Effect on survival. JAMA 1980;44:1806–1807.External Resources

Crossref (DOI)

Vinogradova IE, Ivanina EK: Indicators of cellular immunity and the incidence of infectious-inflammatory diseases during clinico-hematological remission in patients with acute leukemia (in Russian). Ter Arkh 1984;56:46–50. 

Sanz GF, Sanz MA: Complete spontaneous remission in acute myeloblastic leukemia (in Spanish). Rev Clin Esp 1986;178:229–230.External Resources

Pubmed/Medline (NLM)

Zhu XQ, Qian JW: Remission of acute lymphoblastic leukemia of childhood following acute infectious disease. A case report. Chin Med J (Engl) 1986;99:433–434.External Resources

Pubmed/Medline (NLM)

Maekawa T, Fujii H, Horiike S, Okuda T, Yokota S, Ueda K, Urata Y: Spontaneous remission of four months’ duration in hypoplastic leukemia with tetraploid chromosome after blood transfusions and infection (in Japanese). Nippon Ketsueki Gakkai Zasshi 1989;52:849–857.External Resources

Pubmed/Medline (NLM)

Frick S, Frick P: Spontaneous remission in chronic lymphatic leukemia (in German). Schweiz Med Wochenschr 1993;123:328–334.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Delmer A, Heron E, Marie JP, Zittoun R: Spontaneous remission in acute myeloid leukaemia (letter; comment). Br J Haematol 1994;87:880–882.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Musto P, D’Arena G, Melillo L, Cascavilla N, La Sala A, Ladogana S, Carotenuto M: Spontaneous remission in acute myeloid leukaemia: A role for endogenous production of tumour necrosis factor and interleukin-2? (letter; comment). Br J Haematol 1994;87:879–880.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Jono K, Ikebe Y, Inada K, Tsuda H: A case of spontaneous remission in chronic B-cell leukemia with virus infection (in Japanese). Nippon Naika Gakkai Zasshi 1994;83:2159–2160.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Lefrere F, Hermine O, Radford-Weiss I, Veil A, Picard F, Dreyfus F, Flandrin G, Varet B: A spontaneous remission of lymphoid blast crisis in chronic myelogenous leukaemia following blood transfusion and infection. Br J Haematol 1994;88:621–622.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Greentree LB: Anaplastic lung cancer with metastases. Case report of a 15-year survival. Ohio State Med J 1973;69:841–843. 

Marcos Sanchez F, Juarez Ucelay F, Bru Espino IM, Duran-Perez Navarro A: A new case of spontaneous tumor regression (letter; in Spanish). An Med Interna 1991;8:468.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Mentzer SJ: Immunoreactivity in lung cancer. Chest Surg Clin N Am 1995;5:57–71.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Zygiert Z: Hodgkin’s disease: Remissions after measles. Lancet 1971;i:593. 

Ziegler JL: Spontaneous remission in Burkitt’s lymphoma. Natl Cancer Inst Monogr 1976;44:61–65.External Resources

Pubmed/Medline (NLM)

Gattiker HH, Wiltshaw E, Galton DA: Spontaneous regression in non-Hodgkin’s lymphoma. Cancer 1980;45:2627–2632.External Resources

Pubmed/Medline (NLM)

Kempin S, Cirrincione C, Straus DS, Gee TS, Arlin Z, Koziner B, Pinsky C, Nisce L, Myers J, Lee B III, Clarkson BD, Old LJ, Oettgen HF: Improved remission rate and duration in nodular non-Hodgkin lymphoma (NNHL) with the use of mixed bacterial vaccine (MBV). Proc Am Soc Clin Oncol 1981;22:514. 

Kempin S, Cirrincione C, Myers J, Lee B III, Straus DS, Koziner B, Arlin Z, Gee T, Mertelsmann R, Pinsky C, Comacho C, Nisce L, Old LJ, Clarkson BD, Oettgen HF: Combined modality therapy of advanced nodular lymphoma (NL): The role of nonspecific immunotherapy (MBV) as an important determinant of response and survival. Proc Am Soc Clin Oncol 1983;24:56. 

Grem JL, Hafez GR, Brandenburg JH, Carbone PP: Spontaneous remission in diffuse large cell lymphoma. Cancer 1986;57:2042–2044.External Resources

Pubmed/Medline (NLM)

Drobyski WR, Qazi R: Spontaneous regression in non-Hodgkin’s lymphoma: Clinical and pathogenetic considerations. Am J Hematol 1989;31:138–141.External Resources

Pubmed/Medline (NLM)

Wolf JW: Prolonged spontaneous remission of case of malignant lymphoma. Mo Med 1989;86:275–277.External Resources

Pubmed/Medline (NLM)

Sureda M, Subira ML, Martin Algarra S, Prieto Valtuena J, Sangro B: Spontaneous tumor regression. Report of 2 cases (in Spanish). Med Clin (Barc) 1990;95:306–308.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

De Berker D, Windebank K, Sviland L, Kingma DW, Carter R, Rees JL: Spontaneous regression in angiocentric T cell lymphoma. Br J Dermatol 1996;134:554–558.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Sawada M, Ohdama S, Umino T, Tachibana S, Takano S, Miyake S, Yoshizawa Y, Aoki N, Matsubara O: Metastasis of an adenocarcinoma of unknown origin to mediastinal lymph nodes, and transient regression (in Japanese). Nippon Kyobu Shikkan Gakkai Zasshi 1994;32:867–872. 

Heinzlef O, Poisson M, Delattre JY: Spontaneous regression of primary cerebral lymphoma (in French). Rev Neurol (Paris) 1996;152:135–138.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Gunale S, Tucker WG: Regression of metastatic melanoma. Mich Med 1975;74:697–698.External Resources

Pubmed/Medline (NLM)

Wormald RP, Harper JI: Bilateral black hypopyon in a patient with self-healing cutaneous malignant melanoma. Br J Ophthalmol 1983;67:231–235.External Resources

Pubmed/Medline (NLM)

Wagner RF Jr, Nathanson L: Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma. J Am Acad Dermatol 1986;14:249–256.External Resources

Pubmed/Medline (NLM)

Cook MG: The significance of inflammation and regression in melanoma (editorial). Virchows Arch A Pathol Anat Histopathol 1992;420:113–115.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Grafton WD: Regressing malignant melanoma. J La State Med Soc 1994;146:535–539.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Motofei IG: Herpetic viruses and spontaneous recovery in melanoma. Med Hypotheses 1996;47:85–88.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

London RE: Multiple myeloma: Report of a case showing unusual remission lasting two years following severe hepatitis. Ann Intern Med 1955;43:191–201. 

Schurmans JR, Blijenberg BG, Mickisch GH, Schroder FH: Spontaneous remission of a bony metastasis in prostatic adenocarcinoma. J Urol 1996;155:653.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Katz SE, Schapira HE: Spontaneous regression of genitourinary cancer – an update. J Urol 1982;128:1–4.External Resources

Pubmed/Medline (NLM)

Mangiapan G, Guigay J, Milleron B: A new case of spontaneous regression of metastasis of kidney cancer (letter). Rev Pneumol Clin 1994;50:139–140.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Edwards MJ, Anderson JA, Angel JR, Harty JI: Spontaneous regression of primary and metastatic renal cell carcinoma. J Urol 1996;155:1385.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Hunter WS: Unexpected regressed retinoblastoma. Can J Ophthalmol 1968;3:376–380.External Resources

Pubmed/Medline (NLM)

Verhoeff FH: Retinoblastoma undergoing spontaneous regression. Calcifying agent suggested in treatment of retinoblastoma. Am J Ophthalmol 1966;62:573–574.External Resources

Pubmed/Medline (NLM)

Jain IS, Singh K: Retinoblastoma in phthisis bulbi. J All India Ophthalmol Soc 1968;16:76–78.External Resources

Pubmed/Medline (NLM)

Shore BR: Spontaneous cure of congenital recurring connective tissue tumor. Am J Cancer 1936;27:736–739. 

Penner DW: Spontaneous regression of a case of myosarcoma. Cancer 1953;6:776–779. 

Berner RE, Laub DL: The spontaneous cure of massive fibrosarcoma. Plast Reconstr Surg 1965;36:257–262. 

Weintraub LR: Lymphosarcoma. Remission associated with viral hepatitis. JAMA 1969;210:1590–1591.External Resources

Pubmed/Medline (NLM)

Crossref (DOI)

Mizuno S, Fujinaga T, Hagio M: Role of lymphocytes in spontaneous regression of experimentally transplanted canine transmissible venereal sarcoma. J Vet Med Sci 1994;56:15–20.External Resources

Pubmed/Medline (NLM)

Cambridge Scientific Abstracts (CSA)

Lei KI, Gwi E, Ma L, Liang EY, Johnson PJ: ‘Spontaneous’ regression of advanced leiomyosarcoma of the urinary bladder. Oncology 1997;54:19–22.External Resources

Cambridge Scientific Abstracts (CSA)

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Recent Posts

Categories

Translate:

Tags

Translate »
error: Content is protected !!